Department of Neurology and Neuroscience Graduate Program, University of Michigan Medical Center and VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
Dev Dyn. 2020 Jan;249(1):56-75. doi: 10.1002/dvdy.79. Epub 2019 Jul 11.
Human pluripotent stem cells (hPSCs), including embryonic and induced pluripotent stem cells, provide a powerful platform for mechanistic studies of disorders of neurodevelopment and neural networks. hPSC models of autism, epilepsy, and other neurological disorders are also advancing the path toward designing and testing precision therapies. The field is evolving rapidly with the addition of genome-editing approaches, expanding protocols for the two-dimensional (2D) differentiation of different neuronal subtypes, and three-dimensional (3D) human brain organoid cultures. However, the application of these techniques to study complex neurological disorders, including the epilepsies, remains a challenge. Here, we review previous work using both 2D and 3D hPSC models of genetic epilepsies, as well as recent advances in the field. We also describe new strategies for applying these technologies to disease modeling of genetic epilepsies, and discuss current challenges and future directions.
人类多能干细胞(hPSCs),包括胚胎干细胞和诱导多能干细胞,为神经发育和神经网络障碍的机制研究提供了一个强大的平台。自闭症、癫痫和其他神经障碍的 hPSC 模型也在朝着设计和测试精准治疗的方向前进。随着基因组编辑方法的加入,二维(2D)分化不同神经元亚型的方案不断扩展,以及三维(3D)人类大脑类器官培养,该领域正在迅速发展。然而,将这些技术应用于研究复杂的神经障碍,包括癫痫,仍然是一个挑战。在这里,我们回顾了先前使用遗传癫痫的 2D 和 3D hPSC 模型的工作,以及该领域的最新进展。我们还描述了将这些技术应用于遗传癫痫疾病建模的新策略,并讨论了当前的挑战和未来的方向。